ALKERMES | 销售和管理费用

Selling And Administration Expenses 更改 日
AbbVie USD 3.61B 273M 2023-12
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
Amgen USD 1.76B 424M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Malin Corporation EUR 2.2M 800K 2023-06
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Otsuka Holdings JPY 204.45B 7.72B 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



ALKERMES 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.